发明授权
- 专利标题： Compositions and methods related to engineered erythoid cells comprising 4-1BBL
-
申请号： US15716141申请日： 2017-09-26
-
公开(公告)号： US10456421B2公开(公告)日： 2019-10-29
- 发明人: Avak Kahvejian , Jordi Mata-Fink , Robert J. Deans , Tiffany F. Chen , John Round , Noubar B. Afeyan , Torben Straight Nissen , Nathan Dowden , Tom Wickham , Sivan Elloul
- 申请人： RUBIUS THERAPEUTICS, INC.
- 申请人地址： US MA Cambridge
- 专利权人： RUBIUS THERAPEUTICS, INC.
- 当前专利权人： RUBIUS THERAPEUTICS, INC.
- 当前专利权人地址： US MA Cambridge
- 代理机构： Lando & Anastasi, LLP
- 主分类号： A61K35/18
- IPC分类号： A61K35/18 ; A61K35/12 ; A61K38/19 ; A61K39/00 ; A61K39/395 ; C12N5/078 ; A61P17/00 ; C07K14/705
摘要：
The invention includes compositions and methods related to multimodal therapies, e.g., for treating a cancer. A multimodal therapy described herein provides and/or administers a plurality of agents that function in a coordinated manner to provide a therapeutic benefit to a subject in need thereof, e.g., a subject having a cancer.
公开/授权文献
信息查询
IPC分类:
